KTRA insider filings

Kintara Therapeutics, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-10-22. Screen KTRA transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for KTRA between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Kintara Therapeutics, Inc.

FiledFormInsiderReported transactionsSource
2024-10-224Yamashita Dennis — Chief Scientific OfficerGrant/award (A): 196,790 (derivative) @ $0EDGAR
2024-10-224Ng George K — DirectorGrant/award (A): 35,780 (derivative) @ $0 · Grant/award (A): 13,553 (derivative) @ $0 · Grant/award (A): 13,553 (derivative) @ $0EDGAR
2024-10-224List Alan — DirectorGrant/award (A): 13,553 (derivative) @ $0 · Grant/award (A): 13,553 (derivative) @ $0EDGAR
2024-10-224Dearborn Dan — Chief Financial OfficerGrant/award (A): 33,991 (derivative) @ $0 · Grant/award (A): 68,438 (derivative) @ $0 · Grant/award (A): 232,570 (derivative) @ $0 · Grant/award (A): 15,744 (derivative) @ $0 · Grant/award (A): 66,658 (derivative) @ $0EDGAR
2024-10-224MANUSO JAMES S J — DirectorGrant/award (A): 13,553 (derivative) @ $0 · Grant/award (A): 13,553 (derivative) @ $0EDGAR
2024-10-224Bianco James A. — Chief Executive Officer, DirectorGrant/award (A): 2,323,307 @ $0 · Grant/award (A): 357,800 (derivative) @ $0 · Grant/award (A): 71,560 (derivative) @ $0 · Grant/award (A): 191,280 (derivative) @ $0EDGAR
2023-09-014Johnson Laura L. — DirectorGrant/award (A): 8,500 (derivative) @ $0EDGAR
2023-09-014TOTH ROBERT JOSEPH JR — DirectorGrant/award (A): 8,500 (derivative) @ $0EDGAR
2023-09-014Brown Dennis M — Chief Scientific OfficerGrant/award (A): 10,175 (derivative) @ $0EDGAR
2023-09-014FAVORITO TAMARA A — DirectorGrant/award (A): 8,500 (derivative) @ $0EDGAR
2023-09-014Hoffman Robert E. — President, CEO and Interim CFO, DirectorGrant/award (A): 23,142 (derivative) @ $0EDGAR
2023-06-024Hoffman Robert E. — President, CEO, and CFO, DirectorGrant/award (A): 59,800 @ $0EDGAR
2023-01-064Brown Dennis M — Chief Scientific OfficerCode (W): 363 @ $0EDGAR
2022-08-034Brown Dennis M — Chief Scientific OfficerGrant/award (A): 240,087 @ $0 · Grant/award (A): 720,260 (derivative) @ $0EDGAR
2022-08-034Praill Anthony Scott — Chief Financial OfficerGrant/award (A): 240,087 @ $0 · Grant/award (A): 720,260 (derivative) @ $0EDGAR
2022-08-034Hoffman Robert E. — President and CEO, DirectorGrant/award (A): 400,145 @ $0 · Grant/award (A): 1,200,634 (derivative) @ $0EDGAR
2022-07-054TOTH ROBERT JOSEPH JR — DirectorGrant/award (A): 100,000 (derivative) @ $0EDGAR
2022-07-054Johnson Laura L. — DirectorGrant/award (A): 100,000 (derivative) @ $0EDGAR
2022-07-054SEYMOUR TAMARA A — DirectorGrant/award (A): 100,000 (derivative) @ $0EDGAR
2022-02-174Hoffman Robert E. — President and CEO, DirectorPurchase (P): 55,000 @ $0.47EDGAR
2021-12-094Praill Anthony Scott — Chief Financial OfficerPurchase (P): 28,700 @ $0.68EDGAR
2021-12-084Zarrabian Saiid — Head of Strategic Partnerships, DirectorPurchase (P): 11,891 @ $0.59 · Purchase (P): 38,109 @ $0.64EDGAR
2021-11-244Johnson Laura L. — DirectorPurchase (P): 3,000 @ $0.74EDGAR
2021-11-104HOFFMAN ROBERT — President and CEO, DirectorGrant/award (A): 3,519,170 (derivative) @ $0EDGAR
2021-09-224Murphy Keith — DirectorGrant/award (A): 100,000 (derivative) @ $0EDGAR
2021-09-224TOTH ROBERT JOSEPH JR — DirectorGrant/award (A): 100,000 (derivative) @ $0EDGAR
2021-09-224Johnson Laura L. — DirectorGrant/award (A): 100,000 (derivative) @ $0EDGAR
2021-09-224SEYMOUR TAMARA A — DirectorGrant/award (A): 35,000 (derivative) @ $0EDGAR
2021-09-224HOFFMAN ROBERT — DirectorGrant/award (A): 100,000 (derivative) @ $0EDGAR
2021-05-034SEYMOUR TAMARA A — DirectorGrant/award (A): 75,000 (derivative) @ $0EDGAR
2021-04-294Brown Dennis M — Chief Scientific OfficerOther (J): 6 @ $0 · Conversion (C): 750 · Conversion (C): 3,000 (derivative) @ $0EDGAR
2021-04-294TOTH ROBERT JOSEPH JR — DirectorOther (J): 3 @ $0 · Conversion (C): 325 · Conversion (C): 1,300 (derivative) @ $0EDGAR
2021-04-294Praill Anthony Scott — Chief Financial OfficerOther (J): 8 @ $0 · Conversion (C): 938 · Conversion (C): 3,750 (derivative) @ $0EDGAR
2021-03-314TOTH ROBERT JOSEPH JR — DirectorOther (J): 8 @ $0EDGAR
2021-03-314Brown Dennis M — Chief Scientific OfficerOther (J): 17 @ $0EDGAR
2021-03-314Praill Anthony Scott — Chief Financial OfficerOther (J): 22 @ $0EDGAR
2021-01-044TOTH ROBERT JOSEPH JR — DirectorOther (J): 8 @ $0EDGAR
2021-01-044Brown Dennis M — Chief Scientific OfficerOther (J): 17 @ $0EDGAR
2021-01-044Praill Anthony Scott — Chief Financial OfficerOther (J): 22 @ $0EDGAR
2020-09-304TOTH ROBERT JOSEPH JR — DirectorOther (J): 8 @ $0EDGAR
2020-09-304Brown Dennis M — Chief Scientific OfficerOther (J): 17 @ $0EDGAR
2020-09-304Praill Anthony Scott — Chief Financial OfficerOther (J): 22 @ $0EDGAR
2020-09-244Brown Dennis M — Chief Scientifc OfficerGrant/award (A): 60,000 (derivative) @ $0EDGAR
2020-09-244/ABrown Dennis M — Chief Scientific OfficerGrant/award (A): 250,000 (derivative) @ $0EDGAR
2020-09-174TOTH ROBERT JOSEPH JR — DirectorGrant/award (A): 120,000 (derivative) @ $0EDGAR
2020-09-174Murphy Keith — DirectorGrant/award (A): 120,000 (derivative) @ $0EDGAR
2020-09-174Johnson Laura L. — DirectorGrant/award (A): 120,000 (derivative) @ $0EDGAR
2020-09-174Zarrabian Saiid — President and CEO, DirectorGrant/award (A): 2,715,004 (derivative) @ $0EDGAR
2020-09-174Praill Anthony Scott — Chief Financial OfficerGrant/award (A): 606,557 (derivative) @ $0EDGAR
2020-09-174HOFFMAN ROBERT — DirectorGrant/award (A): 120,000 (derivative) @ $0EDGAR

Recent 8-K events — Kintara Therapeutics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-188-K2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-068-K2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-168-K2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-248-K2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-178-K/A5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-178-K2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-168-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-048-K2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-218-K2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=KTRA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs